Friday, 15 Feb 2019

You are here

Daniel Lovell, MD: abatacept in JIA

Dr. Daniel Lovell, a pediatric rheumatologist from the University of Cincinnati/Cincinnati Children's Hospital Medical Center discusses a phase-4 study looking at the effectiveness and safety of abatacept in kids with JIA.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Olga Petryna - Ustekinumab in...

24 Jul 2017

The RheumNow Week in Review - 8...

08 Dec 2017

Dr. Nayef Al Ghanim: RheumNow and RWCS

14 Nov 2016

RheumNow Podcast – Vasculitis and...

14 Dec 2018

Dr. Philip Robinson: Fatigue and...

07 Nov 2017

Jack Cush, MD: ACR Rheumatology Round-Up

16 Nov 2015

Dr. Aryeh Fischer at RWCS 2019

14 Feb 2019

The RheumNow Week in Review – 3 March...

03 Mar 2017

Dr. Olga Petryna: Cardiovascular...

07 Nov 2017

RheumNow Week in Review – 13 May 2016

13 May 2016

RWCS 2017: Adherence to Therapies: What...

21 Feb 2017

Dr. Ian Bruce at ACR 17 - Maintenance...

20 Nov 2017